Simultaneous determination of a new antimalarial agent, CDRI compound 80/53, and its metabolite primaquine in serum by high-performance liquid chromatography
- 1 June 1993
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 616 (1) , 155-160
- https://doi.org/10.1016/0378-4347(93)80483-k
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Methemoglobin Toxicity and Hematological Studies on Malaria Anti-Relapse Compound CDRI 80/53 in DogsThe American Journal of Tropical Medicine and Hygiene, 1989
- Radical Curative Activity of a New 8-Aminoquinoline Derivative (CDRI 80/53) against Plasmodium cynomolgi B in MonkeysThe American Journal of Tropical Medicine and Hygiene, 1989
- Determination of compound identity by group type and class using diode-array detection in high-performance liquid chromatographyJournal of Chromatography A, 1987
- High-Performance Liquid Chromatographic-Ultraviolet Determination of Primaquine and Its Metabolites in Human Plasma and UrineJournal of Pharmaceutical Sciences, 1984
- High-performance liquid chromatography—electrochemical assay method for primaquine in plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- High-performance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metaboliteJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Electron-capture gas chromatographic assay for primaquine in bloodJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Gas chromatography mass spectrometry studies on biologically important 8-aminoquinoline derivativesJournal of Mass Spectrometry, 1978